AACR's Seventh Annual Landon Awards(ment for many patients with non-small ce...),Health

Date:2/21/2008

ment for many patients with non-small cell lung cancer and head and neck cancer. His work, perhaps the most important new development in cancer therapeutics in the past 20 years, has helped define the field of targeted and personalized therapy for cancer. Rarely does a single discovery have such impact in the field of cancer, Gerson added.

A distinguished AACR member, Mendelsohn served as the founding editor of Clinical Cancer Research, a bimonthly translational research journal published by the AACR, and has been a member of the editorial boards of numerous other scientific journals. He has authored more than 300 scientific papers and articles for journals and books, and serves as senior editor of the textbook, The Molecular Basis of Cancer. Mendelsohn has received a number of national and international honors in recognition of his career achievements, including most recently: the Dan David Prize in Cancer Therapy; the Fulbright Lifetime Achievement Medal; the Bristol-Myers Squibb Freedom to Discover Award for Distinguished Achievement in Cancer Research; the David A. Karnofsky Memorial Award from the American Society of Clinical Oncology; the AACR-Joseph H. Burchenal Clinical Research Award; and the Gold Medal of Paris. Mendelsohn earned his bachelors degree in biochemical sciences magna cum laude from Harvard College and received his M.D. cum laude from Harvard Medical School.

The Landon-AACR Prizes in Cancer Research were first presented in 2002 to promote and reward seminal contributions to our understanding of cancer through basic and translational cancer research. These distinguished scientific prizes are designed to bring heightened public attention to landmark achievements in the continuing effort to prevent and cure cancer through quality research.

'/>"/>

Contact: Jennifer Ryan jennifer.ryan@aacr.org 267-646-0558 American Association for Cancer Research Source:Eurekalert

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Hospital Corporation of America Purchases Seventh CyberKnife(R) System
2. 6th Annual Pinot Noir Summit Inspires Passionate Debate
3. SXC Health Solutions to present at Raymond James 29th Annual Institutional Investors Conference
4. CryoCath Technologies notice of annual meeting
5. Stem Cell Experts and New York Lt. Gov. David Paterson to Participate in 3rd Annual Stem Cell Summit as Keynote Speakers
6. Biannual Antibiotics May Cut Major Cause of Blindness in Africa
7. Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting
8. Symposium on drug-resistant diseases set for annual AAAS conference
9. Accipiter Life Sciences Announces Nomination of Three Independent Director Candidates for Election to the Penwest Board at the 2008 Annual Meeting
10. Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference
11. Novo Nordisk Files Annual Report with the SEC